Remimazolam: A Review in Procedural Sedation

Area of Science:

• Pharmacology
• Anesthesiology

Background:

• Procedural sedation is crucial for patient comfort during endoscopic procedures.
• Benzodiazepines are commonly used for sedation, but optimal agents are continually sought.

Purpose of the Study:

• To evaluate the efficacy and safety of remimazolam (Byfavo™) for procedural sedation in adults undergoing endoscopy.
• To compare remimazolam with placebo, including rescue therapy, for sedation and recovery parameters.

Main Methods:

• Three Phase III clinical trials were conducted in adult patients requiring endoscopic procedures.
• Efficacy was assessed by procedure success rates, time to onset of sedation, and time to recovery.
• Safety was monitored through adverse drug reactions, with specific attention to vital signs and concomitant fentanyl use.

Main Results:

• Remimazolam showed significantly higher procedure success rates compared to placebo.
• Patients receiving remimazolam experienced significantly reduced times to sedation onset and recovery.
• Hypotension and hypertension were the most common adverse events; no correlation between sedation depth and vital signs was observed.

Conclusions:

• Remimazolam is an effective and well-tolerated option for procedural sedation in adults.
• Its rapid onset and short recovery times may enhance patient throughput in clinical settings.
• Further pharmacoeconomic analyses are warranted to fully assess its value.